Additional file 1 of Clinical Warburg effect in lymphoma patients admitted to intensive care unit

Additional file 1: Figure S1. Blood glucose levels at admission according to the Clinical Warburg group. Figure S2. Death at 12 months mortality proportions distribution according to the Clinical Warburg group4. Figure S3. Bootstrap sensitivity analysis of the Hazard ratio estimation according to the Clinical Warburg status4. Figure S4. Distribution balance of propensity score5. Figure S5. Kaplan–Meier survival estimates according to the Warburg group after propensity weighting5. Table S1. Baseline characteristics and outcomes of patients excluded due to the absence of serum lactate measurement6. Table S2. Documented localization of the hemopathya7. Table S3. Covariates associated with death at 12 months by unadjusted Cox survival analysis8. Table S4. Covariates associated with death at 12 months by Cox survival analysis (Model 2)9. Table S5. Average Treatment effect on the Treated (ATO) and Odds Ratio (OR) after overlap propensity score 10

MOESM1 of Removal of totally implanted venous access ports for suspected infection in the intensive care unit: a multicenter observational study

Additional file 1: Table 1. Complementary microbiological findings in patients with TIVAP (totally implanted venous-access ports) related infections. Table E2. Complementary microbiological findings in patients without TIVAP (totally implanted venous-access ports) related infections. Table E3. Variables associated with ICU mortality (univariate analysis). Figure E1. Flow chart of the patients. ICU: intensive care unit; TIVAP: totally implanted venous access ports

Distribution of the different alleles in the 106 samples tested for the intronic (A), exonic (B) and intergenic (C) markers.

<p>Distribution of the different alleles in the 106 samples tested for the intronic (A), exonic (B) and intergenic (C) markers.</p

Discriminatory power of the assay for genotyping <i>P</i>. <i>jirovecii</i>.

<p>Discriminatory power of the assay for genotyping <i>P</i>. <i>jirovecii</i>.</p

Transmission map of the 10 patients in whom the <i>P</i>. <i>jirovecii</i> genotype 21 was detected.

<p>The date corresponds to the time at which the patient was present in the hospital and is delineated as a circle. Colored circles show <i>P</i>. <i>jirovecii</i> exposure of a given patient on a given day. Color coding distinguishes the different groups of patients (purple for patients 01–03, blue for patients 04–06 and turquoise for patients 07–10). The red bar corresponds to transmission between two groups of patients. Colored bars show the transmission routes.</p

Summary of genotype categories for <i>P</i>. <i>jirovecii</i> samples.

<p>Summary of genotype categories for <i>P</i>. <i>jirovecii</i> samples.</p

Characteristics of the STR markers and primers used in this study.

<p>Characteristics of the STR markers and primers used in this study.</p

Minimum spanning tree analysis of 61 genotypes from 55 samples harboring a unique genotype (one allele per marker) or multiple genotypes (multiple alleles in one marker).

<p>The number of allelic mismatches among STR profiles was used as distance. Each circle corresponds to one genotype (Gt), with its arbitrary number indicated next to it. The size of the circle is correlated with the number of isolates possessing the corresponding Gt, from one (smallest circle) to nine (Gt21). Dark, dashed and thin connecting bars corresponds to one, 2 or >2 different markers observed between linked genotypes. Gray zones surrounding some groups of circles indicate that these profiles belong to the same genetic cluster, meaning that they have a single allelic mismatch with at least one other member of the group. Cluster 2, which was significantly associated with renal transplant recipients, is shown by a dashed line. The color of the circles indicates the underlying disease of the patient in whom this specific genotype was recovered (Green, HIV patient; Red, hematology patient; Purple, renal transplant recipient; Yellow, other cause of immunosuppression).</p

Supplemental Material, Supplementary_File - Lower Respiratory Tract Infection and Short-Term Outcome in Patients With Acute Respiratory Distress Syndrome

<p>Supplemental Material, Supplementary_File for Lower Respiratory Tract Infection and Short-Term Outcome in Patients With Acute Respiratory Distress Syndrome by Fernando G. Zampieri, Pedro Póvoa, Jorge I. Salluh, Alejandro Rodriguez, Sandrine Valade, José Andrade Gomes, Jean Reignier, Elena Molinos, Jordi Almirall, Nicolas Boussekey, Lorenzo Socias, Paula Ramirez, William N. Viana, Anahita Rouzé, Saad Nseir, and Ignacio Martin-Loeches; on behalf of the TAVeM study group in Journal of Intensive Care Medicine</p

Additional file 2: of The ICU-Diary study: prospective, multicenter comparative study of the impact of an ICU diary on the wellbeing of patients and families in French ICUs

World Health Organization Trial Registration Data Set*. (XLSX 10 kb